A citation-based method for searching scientific literature

Uri Ladabaum, Grace Wang, Jonathan Terdiman, Amie Blanco, Miriam Kuppermann, C Richard Boland, James Ford, Elena Elkin, Kathryn A Phillips. Ann Intern Med 2011
Times Cited: 244







List of co-cited articles
780 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
40

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas Prior, Judith A Westman,[...]. J Clin Oncol 2008
563
36



EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Glenn E Palomaki, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau. Genet Med 2009
340
29

Identification of Lynch syndrome among patients with colorectal cancer.
Leticia Moreira, Francesc Balaguer, Noralane Lindor, Albert de la Chapelle, Heather Hampel, Lauri A Aaltonen, John L Hopper, Loic Le Marchand, Steven Gallinger, Polly A Newcomb,[...]. JAMA 2012
312
29


Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W Prior, Judith Westman,[...]. N Engl J Med 2005
944
26

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
Francis M Giardiello, John I Allen, Jennifer E Axilbund, C Richard Boland, Carol A Burke, Randall W Burt, James M Church, Jason A Dominitz, David A Johnson, Tonya Kaltenbach,[...]. Am J Gastroenterol 2014
275
23

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.
Hans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, Jessica P Gopie, Angel Alonso, Stefan Aretz, Inge Bernstein, Lucio Bertario, John Burn, Gabriel Capella,[...]. Gut 2013
444
23

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.
Francis M Giardiello, John I Allen, Jennifer E Axilbund, C Richard Boland, Carol A Burke, Randall W Burt, James M Church, Jason A Dominitz, David A Johnson, Tonya Kaltenbach,[...]. Gastroenterology 2014
267
21

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
20

Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.
Laura C Beamer, Marcia L Grant, Carin R Espenschied, Kathleen R Blazer, Heather L Hampel, Jeffrey N Weitzel, Deborah J MacDonald. J Clin Oncol 2012
149
19

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
935
19

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Heather Hampel, Wendy Frankel, Jenny Panescu, Janet Lockman, Kaisa Sotamaa, Daniel Fix, Ilene Comeras, Jennifer La Jeunesse, Hidewaki Nakagawa, Judith A Westman,[...]. Cancer Res 2006
400
18

Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.
Brandie Heald, Thomas Plesec, Xiuli Liu, Rish Pai, Deepa Patil, Jessica Moline, Richard R Sharp, Carol A Burke, Matthew F Kalady, James Church,[...]. J Clin Oncol 2013
117
17

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
614
17

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M Schmeler, Henry T Lynch, Lee-may Chen, Mark F Munsell, Pamela T Soliman, Mary Beth Clark, Molly S Daniels, Kristin G White, Stephanie G Boyd-Rogers, Peggy G Conrad,[...]. N Engl J Med 2006
478
17

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Sapna Syngal, Randall E Brand, James M Church, Francis M Giardiello, Heather L Hampel, Randall W Burt. Am J Gastroenterol 2015
723
17

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).
H F Vasen, J P Mecklin, P M Khan, H T Lynch. Dis Colon Rectum 1991
15

Prediction of germline mutations and cancer risk in the Lynch syndrome.
Sining Chen, Wenyi Wang, Shing Lee, Khedoudja Nafa, Johanna Lee, Kathy Romans, Patrice Watson, Stephen B Gruber, David Euhus, Kenneth W Kinzler,[...]. JAMA 2006
249
15

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Tristan Snowsill, Nicola Huxley, Martin Hoyle, Tracey Jones-Hughes, Helen Coelho, Chris Cooper, Ian Frayling, Chris Hyde. Health Technol Assess 2014
80
17

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C R Boland, S N Thibodeau, S R Hamilton, D Sidransky, J R Eshleman, R W Burt, S J Meltzer, M A Rodriguez-Bigas, R Fodde, G N Ranzani,[...]. Cancer Res 1998
14

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
L A Aaltonen, R Salovaara, P Kristo, F Canzian, A Hemminki, P Peltomäki, R B Chadwick, H Kääriäinen, M Eskelinen, H Järvinen,[...]. N Engl J Med 1998
891
12

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Pål Møller, Toni Seppälä, Inge Bernstein, Elke Holinski-Feder, Paola Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf Sijmons,[...]. Gut 2017
256
12

Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.
Marco Di Marco, Elvira DAndrea, Nikola Panic, Valentina Baccolini, Giuseppe Migliara, Carolina Marzuillo, Corrado De Vito, Roberta Pastorino, Stefania Boccia, Paolo Villari. Genet Med 2018
35
34

Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.
Cecelia A Bellcross, Sara R Bedrosian, Elvan Daniels, Debra Duquette, Heather Hampel, Kory Jasperson, Djenaba A Joseph, Celia Kaye, Ira Lubin, Laurence J Meyer,[...]. Genet Med 2012
68
16

Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Lucía Pérez-Carbonell, Clara Ruiz-Ponte, Carla Guarinos, Cristina Alenda, Artemio Payá, Alejandro Brea, Cecilia M Egoavil, Adela Castillejo, Victor M Barberá, Xavier Bessa,[...]. Gut 2012
139
11

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
John Burn, Anne-Marie Gerdes, Finlay Macrae, Jukka-Pekka Mecklin, Gabriela Moeslein, Sylviane Olschwang, Diane Eccles, D Gareth Evans, Eamonn R Maher, Lucio Bertario,[...]. Lancet 2011
602
11

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Elena M Stoffel, Pamela B Mangu, Stephen B Gruber, Stanley R Hamilton, Matthew F Kalady, Michelle Wan Yee Lau, Karen H Lu, Nancy Roach, Paul J Limburg. J Clin Oncol 2015
191
11

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.
H T Lynch, P M Lynch, S J Lanspa, C L Snyder, J F Lynch, C R Boland. Clin Genet 2009
501
11

American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome.
Joel H Rubenstein, Robert Enns, Joel Heidelbaugh, Alan Barkun. Gastroenterology 2015
103
11

Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Heikki J Järvinen, Laura Renkonen-Sinisalo, Katja Aktán-Collán, Päivi Peltomäki, Lauri A Aaltonen, Jukka-Pekka Mecklin. J Clin Oncol 2009
183
11

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.
Tuan A Dinh, Benjamin I Rosner, James C Atwood, C Richard Boland, Sapna Syngal, Hans F A Vasen, Stephen B Gruber, Randall W Burt. Cancer Prev Res (Phila) 2011
123
10

Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
Catherine Julié, Christophe Trésallet, Antoine Brouquet, Céline Vallot, Ute Zimmermann, Emmanuel Mitry, François Radvanyi, Etienne Rouleau, Rosette Lidereau, Florence Coulet,[...]. Am J Gastroenterol 2008
96
10

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, Stephen N Thibodeau, Roberto Labianca, Stanley R Hamilton, Amy J French, Brian Kabat, Nathan R Foster, Valter Torri,[...]. J Clin Oncol 2010
937
10

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
Marjolijn J L Ligtenberg, Roland P Kuiper, Tsun Leung Chan, Monique Goossens, Konnie M Hebeda, Marsha Voorendt, Tracy Y H Lee, Danielle Bodmer, Eveline Hoenselaar, Sandra J B Hendriks-Cornelissen,[...]. Nat Genet 2009
490
10

Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.
Celine H M Leenen, Anne Goverde, Esther W de Bekker-Grob, Anja Wagner, Margot G F van Lier, Manon C W Spaander, Marco J Bruno, Carli M Tops, Ans M W van den Ouweland, Hendrikus J Dubbink,[...]. Genet Med 2016
30
33

A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Tristan Snowsill, Nicola Huxley, Martin Hoyle, Tracey Jones-Hughes, Helen Coelho, Chris Cooper, Ian Frayling, Chris Hyde. BMC Cancer 2015
25
40

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.
Fay Kastrinos, Hajime Uno, Chinedu Ukaegbu, Carmelita Alvero, Ashley McFarland, Matthew B Yurgelun, Matthew H Kulke, Deborah Schrag, Jeffrey A Meyerhardt, Charles S Fuchs,[...]. J Clin Oncol 2017
78
12

Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.
Deborah Cragun, Rita D DeBate, Susan T Vadaparampil, Julie Baldwin, Heather Hampel, Tuya Pal. Genet Med 2014
46
21

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
Ravi N Sharaf, Parvathi Myer, Christopher D Stave, Lisa C Diamond, Uri Ladabaum. Clin Gastroenterol Hepatol 2013
86
11


The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.
Patrice Watson, Hans F A Vasen, Jukka-Pekka Mecklin, Inge Bernstein, Markku Aarnio, Heikki J Järvinen, Torben Myrhøj, Lone Sunde, Juul T Wijnen, Henry T Lynch. Int J Cancer 2008
375
9

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
Marlies J E Kempers, Roland P Kuiper, Charlotte W Ockeloen, Pierre O Chappuis, Pierre Hutter, Nils Rahner, Hans K Schackert, Verena Steinke, Elke Holinski-Feder, Monika Morak,[...]. Lancet Oncol 2011
177
9

Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline.
Scott M Weissman, Randall Burt, James Church, Steve Erdman, Heather Hampel, Spring Holter, Kory Jasperson, Matt F Kalady, Joy Larsen Haidle, Henry T Lynch,[...]. J Genet Couns 2012
89
10

Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators.
Jennifer L Schneider, James Davis, Tia L Kauffman, Jacob A Reiss, Cheryl McGinley, Kathleen Arnold, Jamilyn Zepp, Marian Gilmore, Kristin R Muessig, Sapna Syngal,[...]. Genet Med 2016
26
34

The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history.
Fay Kastrinos, Ewout W Steyerberg, Rowena Mercado, Judith Balmaña, Spring Holter, Steven Gallinger, Kimberly D Siegmund, James M Church, Mark A Jenkins, Noralane M Lindor,[...]. Gastroenterology 2011
135
9

Comparative effectiveness of screening strategies for Lynch syndrome.
Afsaneh Barzi, Sarmad Sadeghi, Michael W Kattan, Neal J Meropol. J Natl Cancer Inst 2015
35
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.